Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 14, 2016BloodOpen Access

The role of whole brain radiation in primary CNS lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

BKBenjamin KasendaUniversity Hospital of Basel
Jay S. Loeffler
Jay S. LoefflerBroad InstituteGIGerald IllerhausKlinikum Stuttgart

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kasenda et al. (2016) studied this question.

synapsesocial.com/papers/6a71ec2e87f9210571286538https://doi.org/10.1182/blood-2016-01-650101
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma2015 · 353 citations
  2. 2Toxic Leukoencephalopathy2001 · 310 citations
  3. 3Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial2016 · 616 citations
  4. 4Long-Term Follow-Up of High-Dose Methotrexate-Based Therapy With and Without Whole Brain Irradiation for Newly Diagnosed Primary CNS Lymphoma2006 · 324 citations
  5. 5Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome2013 · 502 citations